Quantum Biopharma Ltd. (QNTM) shareholders
Close on Nov 17, 2026Market cap $6.18MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Malone Wealth Ventures LLC | 375,752 | 9.80% | 13G (passive) amendment | Feb 3, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of QNTM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 203,564 | 5.24% | $736.90K | +94,973 | 0.09% |
| Jane Street Group, LLC | 48,355 | 1.24% | $175.05K | +16,854 | 0.00% |
| Platform Technology Partners | 41,116 | 1.06% | $148.84K | – | 0.02% |
| UBS Group AG | 33,405 | 0.86% | $120.93K | +26,168 | 0.00% |
| Steward Partners Investment Advisory, LLC | 27,881 | 0.72% | $100.93K | +23,500 | 0.00% |
| Citadel Advisors LLC | 15,863 | 0.41% | $57.42K | – | 0.00% |
| Marex Group plc | 13,436 | 0.35% | $48.64K | −32 | 0.00% |
| Mariner, LLC | 10,000 | 0.26% | $36.20K | −59 | 0.00% |
| Nbc Securities, Inc. | 7,000 | 0.18% | $25.34K | New | 0.00% |
| Osaic Holdings, Inc. | 6,295 | 0.16% | $22.79K | −80 | 0.00% |
| Global Retirement Partners, LLC | 3,000 | 0.08% | $10.86K | New | 0.00% |
| Jones Financial Companies Lllp | 1,209 | 0.03% | $4.59K | +509 | 0.00% |
| Farther Finance Advisors, LLC | 1,000 | 0.03% | $3.62K | – | 0.00% |
| Atlantic Union Bankshares Corp | 1,000 | 0.03% | $3.62K | – | 0.00% |
| Morgan Stanley | 600 | 0.02% | $2.17K | New | 0.00% |
| Royal Bank of Canada | 446 | 0.01% | $2.00K | +427 | 0.00% |
| Wells Fargo & Company/Mn | 250 | 0.01% | $907 | +150 | 0.00% |
| Cetera Trust Company, N.A | 250 | 0.01% | $905 | – | 0.00% |
| Federation des caisses Desjardins du Quebec | 93 | 0.00% | $334 | – | 0.00% |
| SBI Securities Co., Ltd. | 79 | 0.00% | $286 | +4 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 26 | 0M | 10.7% | 4 / 8 | 4 / 3 | 0M | 0M |
| Q1 2026 | 25 | 0M | 6.5% | 7 / 7 | 1 / 6 | 0M | 0M |
| Q4 2025 | 24 | 0M | 3.3% | 9 / 4 | 6 / 2 | 0M | 0M |
| Q3 2025 | 17 | 0M | 1.8% | 4 / 6 | 2 / 4 | 0M | 0M |
| Q2 2025 | 17 | 0M | 3.0% | 6 / 3 | 5 / 3 | 0M | 0M |
| Q1 2025 | 14 | 0M | 1.8% | 7 / 2 | 3 / 2 | 0M | 0M |
| Q4 2024 | 9 | 0M | 1.8% | 1 / 3 | 3 / 4 | 0M | 0M |
| Q3 2024 | 12 | 0M | 1.2% | 12 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
2 funds held QNTM in Q2 2026, 100% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of QNTM | Value | % of fund | As of |
|---|---|---|---|---|---|
| AdvisorShares Psychedelics ETF | 203,564 | 5.24% | $736.90K | 1.66% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -700 | -0.02% | -$2.53K | -0.00% | Jun 30, 2026 |
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Quantum Biopharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 72,930 shares on Sep 11, 2026 over the last 90 days.
See a number that looks wrong?